Acelrx Pharmaceuticals reported $17.07M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 17.07M 1.88M
Acura Pharmaceuticals ACUR:US 1.11M 6.57M
Baxter International BAX:US $ 3441M 97M
Becton, Dickinson and BDX:US $ 6626M 1123M
Biodelivery Sciences International BDSI:US $ 77.66M 13.75M
Cara Therapeutics CARA:US $ 15.53M 358K
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
Pain Therapeutics PTIE:US $ 6.33M 1.69M
Smiths SMIN:LN 987M 97M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Xeris Pharmaceuticals Inc XERS:US $ 37.28M 1.82M
Zogenix ZGNX:US $ 78.43M 9.09M